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 Highlights 
 The cerebellum is a prevalent site of Multiple Sclerosis (MS) disease pathology.  
 Indication of high connectivity between the cerebellum and other CNS regions.  
 Extent of cerebellar MS pathology is comparable to its related network counterparts. 
 Proof of ubiquitous cerebellar involvement in MS dysfunction incl. cognitive decline.  
 New technologies may overcome limitations in assessment of cerebellar dysfunction. 
 Advanced methods are needed to characterize disease dynamics in longitudinal studies. 
 
Abstract  
Despite its functional importance and well known clinical impact in Multiple Sclerosis (MS), the 
cerebellum has only received significant attention over the past few years. It is now established 
that the cerebellum plays a key role not only in various sensory-motor networks, but also in 
cognitive-behavioural processes, domains primarily affected in patients with MS. Evidence from 
histopathological and magnetic resonance imaging (MRI) studies on cerebellar involvement in 
MS is increasingly available, however linking these pathological findings with clinical 
dysfunction remains challenging. There are promising advances in technology that are likely to 
improve the detection of pathological changes within the cerebellum, which may elucidate how 
pathology relates to disability. 
 
Keywords:  
Cerebellum; multiple sclerosis; cognition; atrophy; neurodegeneration; magnetic resonance 
imaging; depth-sensing computer vision. 
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 Introduction  
Simple tasks in daily living such as finding the keyhole, pouring a cup of tea or walking on a 
narrow path can be a major challenge for patients with multiple sclerosis (MS). The cerebellum is 
the brain structure primarily involved in such fine motor, coordination tasks. In fact the defining 
triad of MS recorded by the French neurologist Jean-Martin Charcot (1825–1893), describes three 
predominantly cerebellar symptoms: tremor, nystagmus and scanning speech (Charcot, 1877). 
Beyond this triad, many more symptoms related to cerebellar function, in particular cognitive-
behavioural dysfunction can be disabling for MS patients impairing their daily routine, and predict 
poor prognosis and rehabilitation outcome (de Groot et al., 2009; Langdon and Thompson, 1999; 
Miller et al., 1992). Although cerebellar abnormalities have been known in MS for a long time, 
the cerebellum has received greater attention by MS researchers only during the past two decades. 
The aim of this review is to shed light on the distinctive role of the cerebellum in MS. Starting 
with a review of the complex functional cerebellar anatomy, the histopathological changes in the 
cerebellum of MS patients, their clinical signs and symptoms, the difficulties in capturing the 
latter as well as the clinical-radiological correlations and future research directions are then 
critically discussed.  
 
Functional anatomy of the cerebellum  
While the cerebellum represents only about 10% of the size of the whole brain, with more than 
100 billion neurons, it comprises the same amount of neural cells as the cerebrum (Voogd, 2003). 
This is possible through a characteristic structure of tightly folded cortical grey matter, the foliae, 
which together form the cerebellar lobules of two cerebellar hemispheres including the midline 
vermis. Larsell, and recently revisited by Schmahmann and colleagues, standardized and shaped a 
systematic nomenclature of the individual cerebellar lobules (from I – X), which is applied in 
most magnetic resonance imaging (MRI) studies using cerebellar segmentation techniques 
(Larsell and Jansen, 1972; Schmahmann et al., 1999). In addition to multiple nomenclatures, there 
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 are various anatomico-functional subdivisions of the cerebellum (Manni and Petrosini, 2004). The 
hemispheres can be subdivided in the anterior-posterior direction, namely the anterior, the 
posterior and the flocculonodular lobes. Further distinction is made by afferent sensory input from 
various cortical, subcortical and also spinal regions projecting to the cerebellar cortex, separating 
the so-called cerebro-, vestibulo-, and spino-cerebellum. Another longitudinal division was 
proposed by Jansen and Brodal in a medial, intermediate and lateral zone based on efferent 
feedback projections connecting via the four cerebellar nuclei, embedded in the medullary core of 
the white matter, back to cortical, subcortical and spinal regions of the central nervous system 
(CNS) (Jansen and Brodal, 1954; Voogd, 2003). The fastigial nucleus, most medially located, 
receives input from the medial cortical zone (the vermis), the interposed nuclei (emboliform and 
globose) from the intermediate cortical zone (paravermal zone) and the dentate, the largest and 
most laterally located nucleus is connected with the lateral hemispherical cortical zones.  
Functionally, the cerebellum represents an associative center in multi-synaptic, segregated cortico-
nuclear-thalamo-cortical circuits, involved not only in motor functions, but also, as recently 
recognized, in various higher order cognitive and emotional functions (Koziol et al., 2014). In 
general, lesions in the cerebellum (unlike lesions in the cerebrum) cause a qualitative dysfunction 
rather than a total loss of function; e.g. movements become disorganized, fine-tuning is lost and 
the patients’ speech becomes incomprehensible. Historically, lesional and anatomical studies in 
humans and animals contributed to our understanding of cerebellar dysfunction. It was shown that 
lesions of the cerebellar midline structures (vermis and intermediate zone) predominantly lead to 
impairment of basic motor functions such as limb coordination and balance, whereas pathology in 
the lateral cerebellar hemispheres cause dysfunction in higher motor functions and cognitive 
processes (Konczak and Timmann, 2007; Schmahmann and Sherman, 1998). The precise 
somatotopic organization of the cerebellar cortex especially regarding higher order functions, has 
been the subject of an intense discussion and reappraisal over the years. Similar to the functional 
compartmentalization of the cerebral homunculus, a systematic cortical representation of body 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 parts is also postulated in the cerebellum (Manni and Petrosini, 2004). Functional imaging studies 
and intraoperative mapping improved understanding of functional compartmentalization and 
helped to better understand the cerebellar cortical topography (Buckner et al., 2011; Mottolese et 
al., 2013; Stoodley and Schmahmann, 2010). Ipsilateral body movements follow a reliable 
topography mainly, but not exclusively, in the anterior lobe and lobule VI of the cerebellum, 
where different sectors may represent the same body part or vice versa and the size of the cortical 
representation is proportional to its functional importance (Mottolese et al., 2013). A second 
motor cortical–cerebellar loop is represented in lobule VIII with further hand/arm and lower limb 
representation (Buckner et al., 2011; Mottolese et al., 2013). Situated in between these two motor 
task-dominated regions, the largest lobule, lobule VII (subdivided in Crus I, II and VIIb), is 
activated during various language, working memory and executive function tasks (Stoodley and 
Schmahmann, 2010). Language tasks, e.g. verb generation tasks, further activate parts of the 
adjacent Lobule VI (Thurling et al., 2011). The latter cerebellar region is proposed to participate 
in higher-order cognitive networks with at least three cortical regions, including the dorso-lateral 
prefrontal, inferior parietal and lateral temporal area (Buckner et al., 2011).  
Patients with MS suffer not only from the clinically more obvious cerebellar motor dysfunction, 
e.g. gait ataxia, tremor or ocular motor dysfunction, but also from a specific cognitive deficit 
profile, likely related to cerebellar dysfunction, which is discussed below.  
 
Neuronal Models of the Cerebellum: From Cells to Neurological Conditions  
Since the first description of neurons by Camillo Golgi and Santiago Ramón y Cajal at the 
beginning of the last century, the cerebellum has been attractive for its regular network structure 
and clear identification of the different neuronal types. The two main questions that arose at that 
time and remain under investigation are: (1) how does the cerebellum operate and (2) what is the 
role of the cerebellum in overall brain functioning. Understanding these points, in turn, brings 
about relevant consequences for neuropathology (D'Angelo, 2010; D'Angelo et al., 2011). 
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 Intense investigation in molecular, cellular and circuit physiology has revealed relevant properties 
of cerebellar neurons and synapses (D'Angelo and De Zeeuw, 2009). Moreover, various kinds of 
mathematical models have been devised to investigate whether the cerebellum microcircuit 
functions can be explained in terms of its elementary neuronal and synaptic properties. Recently 
detailed computational models of neurons and synapses based on physiological measurements 
have been developed to generate a bottom-up reconstruction of the cerebellar microcircuit, 
showing how spatio-temporal reconfiguration of input signals and internal microcircuit 
computations take place (D'Angelo et al., 2013; Solinas et al., 2010). 
A critical issue is that, whilst it is well known that the cerebellum is involved in learning and 
memory of sensory motor skills, the way these processes take place is still unclear (D'Angelo, 
2014). The initial proposal, drawing on Motor Learning Theory, suggested that learning had to 
occur at the parallel fiber - Purkinje cell synapse under supervision of climbing fibers (Marr, 
1969). However, the uniqueness of this mechanism has been questioned and multiple forms of 
long-term plasticity have been revealed at various locations in the cerebellar circuit, including 
synapses and neurons in the granular layer, molecular layer and deep cerebellar nuclei. At present, 
more than 15 forms of plasticity have been reported. There has been a long debate on which 
plasticity is more relevant to specific aspects of learning, but this question has been hard to 
resolve using physiological analysis alone. Recent experiments and models making use of closed-
loop robotic simulations are revealing a radically new view: one single form of plasticity is 
insufficient whilst altogether the different forms of plasticity can explain the multiplicity of 
properties characterizing cerebellar learning (Casellato et al., 2014; Solinas et al., 2010). These 
include multi-rate acquisition and extinction, reversibility, self-scalability and generalization. 
Moreover, when the circuit embeds multiple forms of plasticity, it can easily cope with multiple 
behaviors, allowing the cerebellum to operate as an effective generalized forward controller. 
The functional role of the cerebellum has recently been reassessed using transcranial magnetic 
stimulation (TMS), showing that it effectively controls both sensori-motor integration (Monaco et 
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 al., 2014) and cognitive processing (Cattaneo et al., 2014). High-resolution MRI tractography has 
revealed a remarkable connectivity not just with motor but also with associative cortical areas 
(Palesi et al., 2014) and functional MRI (fMRI) has shown that the cerebellum is part of numerous 
cognitive resting-state networks (Castellazzi et al., 2014) and in consequence is prominently 
involved in neurodegenerative pathologies like Alzheimer’s Disease (Castellazzi et al., 2014) and 
in MS.  
 
Pathology of cerebellar abnormalities in MS 
The cerebellum is a predilection site for lesion development in MS. Both grey (GM) and white 
matter (WM) demyelination are observed, the former representing the most prominent 
pathological feature (Figure 1). Analogous to cortical demyelination in other brain regions 
(Kutzelnigg et al., 2005), several histopathological studies highlighted the presence of cerebellar 
cortical demyelination, in particular in progressive MS. Demyelination in the cerebellar GM is 
more extensive than in the WM, usually affecting one or more cerebellar foliae and comprising, 
on average, ~14-39% and up to ~80-90% of the total cerebellar GM area (Gilmore et al., 2009; 
Howell et al., 2014; Kutzelnigg et al., 2007). Morphologically, cortical demyelination presents 
mainly as confluent lesions affecting all layers of the cerebellar cortex in a band-like subpial 
manner, yet leukocortical lesions as well as intracortical perivenous lesions have also been 
described (Gilmore et al., 2009; Kutzelnigg et al., 2007). The extent of cortical demyelination in 
the cerebellum seems to be related to the extent of overall MS pathology, associated with the 
amount of cortical demyelination in the forebrain (Kutzelnigg et al., 2007) and the overall 
proportion of demyelinated GM (Gilmore et al., 2009).  
In contrast to late stage MS, cerebellar cortical demyelination in early MS has been described as 
sporadic in histopathological studies, with a percentage of demyelination in the range of 0-7.5% 
(Kutzelnigg et al., 2007), thus favoring the view that GM lesions reflect cumulative – or late stage 
– pathology (Gilmore et al., 2009). 
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 Cerebellar cortical lesions are associated with neuronal loss and axonal damage (Kutzelnigg et al., 
2007; Redondo et al., 2014), an attribute common to cortical lesions in other locations in the 
CNS(Peterson et al., 2001). However, contrary to the brain (Wegner et al., 2006) and 
hippocampus (Dutta et al., 2011), no differences in the synaptic density were observed between 
myelinated and demyelinated regions in the cerebellum (Kutzelnigg et al., 2007). It is 
conceivable, however, that these discrepancies may in part arise from differences in the sensitivity 
of the methods applied. 
Mechanistic considerations also suggest similarities between GM pathology in the brain and 
cerebellum in late stage MS. In particular, a prominent role for inflammation in GM pathology has 
been proposed. Similarly to the brain, subpial GM demyelination in the cerebellum has been 
related to the presence of meningeal inflammation (Howell et al., 2014; Kutzelnigg et al., 2005). 
The extent of GM demyelination correlated with meningeal macrophage density and microglial 
activation in the GM (Howell et al., 2014). Interestingly, both demyelination and meningeal 
inflammation were more pronounced in patients harboring B cell accumulations in forebrain 
regions. The role of inflammation as a major contributor to cortical cerebellar pathology is further 
underscored by experimental data. Particularly myelin oligodendrocyte glycoprotein (MOG)1-125-
induced experimental autoimmune encephalomyelitis (EAE) in the common marmoset has been 
instrumental in studying the relationship between focal cortical lesions and cortical atrophy in the 
brain and the cerebellum (Merkler et al., 2006). As in chronic MS, where an overall cortical 
thinning occurrs independently of focal cortical demyelination (Wegner et al., 2006), marmosets 
with EAE also show diffuse cortical thinning, diffuse axonal damage and synaptic loss in both 
demyelinated and myelinated cortex (Pomeroy et al., 2010). The diffuse nature of cortical 
pathology suggests the involvement of soluble inflammatory factors, a hypothesis that was further 
substantiated in other experimental models of MS (Pomeroy et al., 2010; Yang et al., 2013). 
Moreover, inflammation has been shown to induce functional alterations in synaptic input 
AC
CE
PT
ED
MA
NU
SC
RI
PT
 (Mandolesi et al., 2012) to Purkinje cells and in their ion channel composition, thus leading to 
changes in their firing properties (Shields et al., 2012).  
Altogether, the cerebellum presents itself as a predilection site for focal demyelinated lesions in 
the white, but also especially in the grey matter. The extent of tissue damage seems to be related 
to the overall severity of MS-related pathology. However, histopathological reports showing 
significant widespread neuronal and axonal degeneration in the cerebellum in MS suggest that 
diffuse generalized cerebellar pathology is at least in part independent of focal lesions. 
Experimental data support these findings and indicate potential molecular correlates underlying 
diffuse cerebellar changes. Although there are emerging insights into the mechanisms of 
cerebellar pathology, further work is needed to fully elucidate the interplay between inflammation, 
demyelination, and neuroaxonal pathology in MS. 
 
Cerebellar involvement in Clinically Isolated Syndromes - Clinical symptoms and lesional 
MRI features  
Clinically isolated syndromes (CIS) suggestive of MS represent first clinical attacks of MS. These 
syndromes are usually categorised in terms of topography of the suspected underlying lesion: 
optic neuritis, myelitis and CIS of the brainstem and/or cerebellum. While features of attacks of 
optic neuritis and, less so, myelitis are clinically well defined and may be thought to represent a 
single clinical entity even though lesions may affect distant parts of the optic nerve or spinal cord, 
clinical manifestations of CIS in the brainstem and/or cerebellum are diverse, and multiple 
combinations of signs and symptoms are possible (McDonald and Compston, 2006). From a 
clinical point of view, it is often difficult to differentiate cerebellar from brainstem syndromes and 
these two topographies are therefore usually considered together. 
In a retrospective analysis of CIS with brainstem/cerebellar symptoms (assessed within 3 months 
of onset) the most common symptoms noted were: diplopia (68%), facial sensory symptoms 
(32%) and gait disturbance (31%) (Sastre-Garriga et al., 2010). Regarding MRI findings, the 
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 presence of 2 or more infratentorial lesions was related to long-term disability in a small study 
with 42 patients with CIS followed for 8.7 years (Minneboo et al., 2004). In another large CIS 
cohort of 146 patients followed for a median of 7.7 years, patients with infratentorial lesions had a 
higher risk of a second attack and the presence of infratentorial lesions further increased the risk 
for disability (Tintore et al., 2010). In this regard brainstem rather than cerebellar lesions were 
responsible for the poor prognosis.  
In the 2001 and 2005 MS diagnostic criteria, definition of dissemination in space was based on 
Barkhof’s MRI criteria which have shown a high specificity for predicting conversion to clinically 
definite MS (CDMS) (Barkhof et al., 1997; Montalban et al., 2010). However, the presence of an 
infratentorial lesion, one of the four Barkhof criteria, was less specific, compared with specificity 
in other topographies in CIS (Sastre-Garriga et al., 2004). Because of this lower specificity and 
because the symptomatic lesion is not in itself demonstrating dissemination in space, the 2010 
McDonald criteria foresee that the symptomatic lesions should not contribute to the lesion count 
(Polman et al., 2011). However, if the symptomatic lesion has to be excluded, CIS patients with 
one single symptomatic lesion in the brainstem/cerebellum would be seen as CIS patients with 
zero brain MRI lesions. Tintore et al. showed that, in fact, brainstem/cerebellum or spinal cord 
syndromes with a unique symptomatic lesion had a higher risk of developing CDMS and 
disability than patients without lesions (Tintore et al., 2016). Therefore, despite the 
recommendations of the 2010 McDonald criteria, the symptomatic lesion seems to matter in terms 
of risk of developing CDMS and should also contribute to dissemination in time (Kang et al., 
2014; Tintore et al., 2016). 
 
Automated quantification of cerebellar dysfunction signs and symptoms in multiple sclerosis 
using depth-sensing computer vision  
Motor cerebellar signs and symptoms (e.g. tremor, gait or truncal ataxia, oculomotor disturbance) 
may be the predominant clinical manifestation in 11–33% of patients with MS (Weinshenker et 
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 al., 1996).  It was shown that patients demonstrating cerebellar dysfunction early in the disease 
course tend to develop severe disability more quickly (Amato and Ponziani, 2000). Especially in 
progressive disease courses, motor dysfunction, frequently cerebellar in nature, is a major 
contributor for reduced mobility and quality of life (Feinstein et al., 2015). So far, the Expanded 
Disability Status Scale (EDSS) assessment remains the most widely used clinical outcome 
measure and the only scale accepted by most health agencies for approval of MS therapeutics 
(Cohen et al., 2012; Kurtzke, 1983). However, the EDSS has well-known shortcomings, 
especially its high inter-rater and intra-rater variability (Goodkin et al., 1992). Higher consistency 
and potentially higher sensitivity is particularly relevant for detection of subtle changes in 
patients’ neurological performance, e.g. in fine motor tasks related to cerebellar pathology. A 
promising alternative is offered by the “Assess MS” system, which has been developed as a 
touch-free, consistent and potentially finer grained tool to measure motor dysfunction - including 
cerebellar signs - in MS (Kontschieder et al., 2014; Morrison et al., 2015). Based on advanced 
machine learning algorithms (MLA), “Assess MS” automatically analyzes 3D-depth-sensor 
(Kinect camera) recordings of patients performing standard tests of motor function. The MLA are 
trained by Neurostatus-EDSS scorings (Kappos, 2011) performed by trained neurologists. The 
agreement between the MLA and the neurologists' scores are compared with the neurologists' 
short- and long-term intra-rater agreement. First results of a proof-of-concept multi-centre study 
are promising (D'Souza et al., 2016). 
To validate future automated assessments, a video-based system has been developed, whereby 
pairwise comparisons of patient videos assessed by neurologists, can be mapped onto a 
continuous scale using the TrueSkill™ algorithm (Herbrich et al., 2007). First unpublished results 
demonstrate that the mapping of comparative assessment scores based on the TrueSkill™ 
algorithm appear to be much more sensitive to the variability in patients’ neurological 
performance than ordinal measures, resulting in finer increments than the Neurostatus-EDSS 
subscores, with high intra- and inter-rater consistency on average 80-100%.  
AC
CE
PT
ED
 M
AN
US
CR
IPT
 Automated computer assisted systems may overcome current problems in the reliable assessment 
of disability, especially providing a more sensitive (and potentially more specific) tool for 
measuring cerebellar dysfunction. 
 
The Cerebellum and Cognition in MS  
The cerebellar role in cognition has been recognized more recently and was first described as the 
cerebellar cognitive-affective syndrome (CCAS) (Schmahmann and Sherman, 1998). The CCAS 
includes, amongst other domains, impairment of executive functions such as planning, verbal 
fluency, abstract reasoning, working memory, visual–spatial skills and memory, many of which 
are frequently affected in patients with MS (Chiaravalloti and DeLuca, 2008). Studies on MS 
patients with cerebellar motor dysfunction showed that these patients may have a different 
cognitive profile compared to those without cerebellar symptoms, performing less well on tests of 
information processing speed and verbal fluency (Cerasa et al., 2013b; Valentino et al., 2009; 
Weier et al., 2014b) and less commonly on memory tasks (Cerasa et al., 2013b) and the Stroop 
test (Cerasa et al., 2012) (Table 1). In relapsing-remitting MS (RRMS) patients with cerebellar 
motor signs Symbol Digit Modality Test (SDMT) scores correlated with GM volume in the right 
dorsolateral prefrontal cortex and verbal fluency correlated with GM volume in the left superior 
temporal gyrus (Cerasa et al., 2013b). An fMRI group comparison of RRMS with and without 
cerebellar signs using a Paced Auditory Serial Addition Test (PASAT) paradigm revealed only 
one difference, which was overactivation in the left cerebellum (Crus I) and reduced connectivity 
between the left Crus I and the right superior parietal lobule (Cerasa et al., 2012). 
In unselected MS groups, higher cerebellar leukocortical lesion load has been linked to poorer 
PASAT performance, whereas poorer SDMT scores have been linked with greater cerebellar 
intracortical lesion burden (Damasceno et al., 2014), although not always (Valentino et al., 2009). 
Lesion occurrence in particular within the middle cerebellar peduncles (MCP) may lead to 
cognitive impairment by damaging important connecting pathways (Tobyne et al., 2017). 
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 Cerebellar volume has been significantly albeit weakly related to both PASAT and SDMT 
performance (Weier et al., 2014b).  Especially posterior lobe damage was shown to be associated 
with reduced performance in information processing speed tasks (Moroso et al., 2017). 
FMRI experiments have utilised a range of cognitive tasks, which have implicated the cerebellum 
to varying degrees in particular when testing executive function. The go/no-go task increased 
cerebellar activation for MS patients (Loitfelder et al., 2014), the Stroop test demonstrated 
increased connectivity between the right inferior frontal gyrus and the right cerebellum in benign 
MS patients (Rocca et al., 2009), and the Tower of London paradigm increased activation for MS 
patients in the cerebellum (Lazeron et al., 2004). Information processing speed tasks have also 
shown cerebellar involvement.  The n-back task demonstrated increased cerebellar activation in 
cognitively impaired primary progressive (PP) MS (Rocca et al., 2010b). The PASAT 
demonstrated more right cerebellar activation in patients with CIS who were cognitively impaired 
(Forn et al., 2012) and also in unselected CIS (Audoin et al., 2003).  
Interestingly, in a small trial, rivastigmine improved cognitive performance on the verbal PASAT 
and increased right cerebellar activation (Huolman et al., 2011).  Two studies on the effects of 
cognitive rehabilitation have concordantly highlighted that cognitive rehabilitation promoted 
cerebellar recruitment during the performance of cognitive tasks (Cerasa et al., 2013a; Sastre-
Garriga et al., 2011), thus linking higher cerebellar recruitment with better cognitive performance 
(Cerasa et al., 2013a).                                                                                               
Although clearly implicated in cognitive function in MS, the precise processing contribution of 
the cerebellum is not yet elucidated.  It has been suggested that the cerebellum’s role is to 
automate subroutines, thus freeing up the anterior areas of the cerebrum to manage novelty and 
more elaborate planning. For information processing speed tasks, where learning and efficient 
processing are essential to support optimal performance, the contribution of the cerebellum is 
clear. However, recently theories of cerebellar function have started to embrace much broader 
concepts of internal modelling, which incorporate the formidable processing capacity of the 
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 cerebellum and its ability to co-ordinate many different inputs (Ito, 2008). These internal model 
theories have mainly concentrated on motor processing, but by extension cognitive internal 
models could also be hypothesised, providing neural representations of the external world (Koziol 
et al., 2014). This might explain the ubiquitous involvement of the cerebellum in MS dysfunction, 
including cognitive decline. It might also help increase understanding of why cerebellar pathology 
has such a wide-ranging negative impact on the lives of MS patients. 
 
Relation of structural and functional abnormalities of the cerebellum with physical 
disability in MS 
Several structural and functional imaging techniques have been applied to investigate the extent of 
cerebellar involvement in MS patients and its contribution to the clinical manifestations of the 
disease (see summary in Table 1). While cerebellar T2 hyperintense lesions are frequent, 
especially in the progressive disease phenotypes (Ormerod et al., 1987), correlation between the 
extent of these lesions and disability was relatively modest. More recently, cerebellar T2-
hyperintense lesions have been associated with recurrent falls in MS patients (Prosperini et al., 
2011). Infratentorial T1 hypointense lesions, which represent areas of severe tissue damage and 
permanent axonal loss, were frequent in MS patients with chronic cerebellar ataxia and correlated 
with the severity of disability (Hickman et al., 2001). While histopathological studies have 
revealed more pronounced demyelination in the cortex than the white matter, current in vivo 
imaging techniques are very limited in their sensitivity towards cortical lesions. Double Inversion 
Recovery (DIR) and Phase Sensitive Inversion Recovery (PSIR) MRI sequences may help to 
better identify cortical lesions within the cerebellum (Calabrese et al., 2010; Favaretto et al., 
2016), however a clear distinction between purely intracortical, subcortical or mixed lesions is not 
(yet) possible. Studies revealed moderate to strong correlations between the cortical lesion burden 
and clinical measures of cerebellar motor and cognitive dysfunction (Calabrese et al., 2010; 
Damasceno et al., 2014; Favaretto et al., 2016). Cerebellar GM involvement in MS has also been 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 investigated in terms of T2 hypointensity (Tjoa et al., 2005) (which are likely to reflect increased 
iron content) of cerebellar nuclei, in particular the dentate nucleus. These signal abnormalities 
correlated with the severity of clinical disability (Tjoa et al., 2005).  
Several authors applied diffusion tensor (DT) MRI and different methods of analysis to 
investigate the integrity of cerebellar WM connections and its clinical relevance in MS. 
Microstructural alterations in the cerebellar WM can already be found early in the disease course 
and even in absence of focal lesions (Deppe et al., 2016). Using DT tractography, abnormalities of 
the main cerebellar connections have been found in PPMS patients and were significantly 
associated with worse upper limb function and walking ability (Anderson et al., 2011).  
Investigations on the contribution of structural disconnection between the cerebellum and cerebral 
hemispheres to clinical outcome using measures of global brain and cerebellar injury as well as 
DT MRI metrics, showed a higher probability of T2 lesions and more severe diffusivity 
abnormalities in the MCP and superior cerebellar peduncles (SCP) in MS patients with clinical 
impairment involving ambulation, and the cerebellar and brainstem functional systems (Preziosa 
et al., 2014) (Figure 2). More importantly, such diffusivity measures of MCP or SCP damage 
distinguished clinically impaired from unimpaired patients better than volumetric measures of T2 
lesions or cerebellar atrophy (Preziosa et al., 2014). In ambulatory MS patients, balance 
impairment was correlated with worse DT MRI indices along the cerebellar connections and 
supratentorial associative WM bundles (Prosperini et al., 2013). In a 12-week intervention trial 
using visual feedback training with a video game balance board system, improved standing 
balance at static posturography was correlated with modifications of diffusivity parameters of the 
SCPs. Unfortunately, both clinical and DT MRI changes did not persist beyond 12 weeks after 
training, suggesting an impaired structural plasticity in these patients (Prosperini et al., 2014).  
The role of cerebellar functional plasticity for disease clinical manifestations has been explored 
using fMRI during both active tasks or at rest. Abnormal activation and functional connectivity of 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 the cerebellum has been found in adult MS patients compared to matched healthy controls (Rocca 
et al., 2007; Saini et al., 2004) and pediatric MS patients (Rocca et al., 2010a) during the 
performance of motor tasks. The correlation found between these fMRI abnormalities and the 
severity of structural damage of the underlying WM tracts suggests an adaptive role of functional 
connectivity changes in limiting the clinical consequences of structural damage in these patients 
(Rocca et al., 2007). Abnormal cerebellar functional connectivity has also been demonstrated in 
MS using resting state fMRI and has been correlated with more severe clinical disability and 
ataxia and was influenced by higher lesion volumes (Dogonowski et al., 2014).  
First promising approaches on improving cerebellar motor dysfunction in MS have been shown 
using transcranial magnetic stimulation in two small studies (Elzamarany et al., 2016; Koch et al., 
2008).  
 
Cerebellar atrophy in MS  
Progressive brain volume loss is a common feature in MS, occurs early in the disease course, 
reflects damage in the WM and GM, and has been associated with disability (De Stefano et al., 
2014; Filippi et al., 2012). For a long time, cerebellar volume loss was not the primary focus of 
MRI research, partly due to technical challenges concerning correct segmentation of the thin 
cerebellar gyri, sulci and cerebellar nuclei and extracting the cerebellar tissue from adjacent 
infratentorial structures. Whilst commonly used automated segmentation tools (e.g. ANIMAL 
(Collins et al., 1995), FreeSurfer (Fischl et al., 2002), SPM (Ashburner and Friston, 2005) etc.) for 
volumetric studies have been primarily developed and validated for the whole brain or 
supratentorial structures, detailed (semi-) automated methods focusing on the cerebellum as a 
whole or - even more demanding - allowing segmentation of its individual lobules were developed 
only recently (Diedrichsen et al., 2009; Park et al., 2014; Weier et al., 2012; Weier et al., 2014a). 
Few cross-sectional studies have addressed the question of cerebellar atrophy in particular and its 
clinical relevance in MS up to date (see summary in Table 1). Generally speaking, these studies 
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 show a reduction of the total cerebellar volume in MS patients when compared to healthy 
controls, more pronounced in the progressive disease forms (Anderson et al., 2009; Davie et al., 
1995; Ramasamy et al., 2009; Weier et al., 2012). However, study results are heterogeneous 
regarding the distribution of the disease burden in cerebellar WM and GM, the different disease 
courses and in terms of the associated clinical impact of such volume loss. In CIS patients, 
cerebellar GM volume loss was evident only in one small cohort investigated by Calabrese and 
colleagues (Calabrese et al., 2010), whereas other groups did not find significant GM volume 
differences in the cerebellum of CIS and HC (Anderson et al., 2009; Henry et al., 2008). 
However, Ramasany and colleagues found reduced WM volumes in a cohort of CIS and MS 
patients (Ramasamy et al., 2009). Comparing patients with benign MS to patients with secondary 
progressive MS, the cerebellum was the only region showing a reduction of GM in the 
progressive patients (Mesaros et al., 2008). Anderson and colleagues also found a reduced 
cerebellar GM volume in SPMS patients when compared to HC and a borderline GM volume 
reduction in the cerebellum of RRMS patients (Anderson et al., 2009). A reduction of cerebellar 
white matter volume was only seen in progressive patients. Only cerebellar GM volume was a 
significant predictor of cerebellar dysfunction, which led the authors to conclude that cerebellar 
GM atrophy may be related to progressive disability. In contrast, clinical dysfunction during the 
relapsing-remitting phase rather relates to the accumulation of focal white matter damage within 
the brain and spinal cord.  
Interpretation of these studies must be cautious, because the distinction of “pure” GM and WM in 
the thin cerebellar foliae is particularly challenging with existing methodologies. Further, 
cerebellar volume loss in RRMS patients may be more subtle and therefore not be detectable with 
global segmentation techniques (Figure 3).  
Correlations of cerebellar volume with clinical measures such as the EDSS are at best moderate 
(Calabrese et al., 2010) or not significant (Davie et al., 1995; Mesaros et al., 2008; Ramasamy et 
al., 2009; Weier et al., 2012). More specific tests - such as the depth-sensing video recordings 
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 with machine learning methods discussed above - may in the future better reflect cerebellar 
function than global clinical assessments such as the EDSS. This may help to give a clearer 
picture of the clinical impact of cerebellar damage. Indeed studies using fine motor skills 
(Anderson et al., 2009; Henry et al., 2008) or cognitive-behavioural dysfunction (Weier et al., 
2014b; Weier et al., 2016b) as major outcome measures showed a more robust correlation with 
cerebellar atrophy.  
The application of novel automatic cerebellar segmentation techniques allows lobe- or even 
lobule-wise determination of volumes and their disease-related changes (Weier et al., 2014a). In a 
prospective cohort of pediatric patients with monophasic acquired demyelinating syndromes and 
pediatric-onset MS, a failure of age-expected growth of the cerebellum, in particular of the 
posterior lobe was found when comparing their cerebellar growth trajectory to healthy children 
(Weier et al., 2016a). Another matched-control study on pediatric-onset MS patients revealed that 
smaller cerebellar posterior lobe volume adversely impacts cognitive function, in particular 
measures for information processing speed and vocabulary (Weier et al., 2016b), underlining the 
role of cerebellar pathology also in pediatric-onset MS patients. Similar results were found in a 
study on adult relapse-onset MS patients (D'Ambrosio et al., 2016). 
Cerebellar volumes were further analysed with respect to possible secondary degeneration of the 
spino-cerebellar tract after inflammatory spinal cord pathology in patients with neuromyelitis 
optica (NMO; an important differential diagnosis to MS) and compared to matched patients with 
RRMS and healthy controls (Weier et al., 2015). While atrophy seemed to be diffuse in MS 
patients involving both supratentorial and infratentorial structures (but less so the upper cervical 
cord), NMO patients presented with a rather localized pattern with predominant involvement of 
the upper cervical cord, but normal total cerebellar volume.  
 
Conclusions and future directions 
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 This review of the increasing number of basic science, neuropathology and imaging studies 
clearly emphasizes the cerebellum as a prevalent site of MS disease pathology. The high 
connectivity between the cerebellum and other CNS regions makes it difficult to be precise about 
its role in clinical disability and its correlation to pathology, especially in the early phases of the 
disease. Novel automated depth-sensing computer vision techniques combined with machine 
learning algorithms may overcome current limitations regarding the reliable clinical assessment of 
cerebellar dysfunction. First promising results show how cerebellar dysfunction may be 
successfully treated in the future. Further advances in imaging, e.g. higher field strength combined 
with multimodal approaches including advanced functional and structural imaging, will help to 
further improve our understanding of the functional consequences of cerebellar pathology. 
Reliable and accurate methods are needed to characterize disease dynamics in longitudinal studies 
and larger patient cohorts to support and extend the results from cross-sectional studies.  
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 Figure Captions:  
Figure 1: Cerebellar histopathology of MS.  
 
Microphotographs of the dentate nucleus and cerebellar cortex obtained from autopsy material of 
an MS patient. Demyelinating lesions can be clearly visualized using the Luxol Fast Blue – 
Periodic acid-Schiff staining (A, arrow; B) and often localize to the deep cerebellar nuclei (Ai). 
Similar to other brain regions, the lesions present clearly delineated borders (B, black 
arrowheads) and a reduction in the axonal density, which becomes apparent in the Bielschowsky 
silver impregnation (C). Note that the structure of the dentate nucleus is largely preserved (B-C, 
yellow arrowheads). D. Synaptophysin immunhistochemistry of the cerebellar cortex (from the 
region marked as Aii). Previous studies3 detected no differences in the density of 
immunoreactivity between demyelinated and normal areas of the granular cell layer (GCL) in MS. 
E. Hematoxylin-eosin staining showing Purkinje cells. A reduction in the Purkinje cell density 
was associated with cerebellar cortical lesions in MS 3,6. PCL: Purkinje cell layer. ML: Molecular 
layer.  
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 Figure 2: Cerebellar pathways damage and clinical disability. 
 
SPM analysis (red color-coded for t values; p <0.05, corrected for multiple comparisons) of 
clusters with increased mean diffusivity (MD) and radial diffusivity (RD), reduced FA and 
increased probability of having T2 lesions (blue) in the middle cerebellar peduncle (MCP) of 
multiple sclerosis (MS) patients according to the different subgroup dichotomization. Upper rows: 
patients with Expanded Disability Status Scale (EDSS) score ≥ 4.0 vs patients with EDSS < 4.0. 
Middle rows: patients with cerebellar functional system (CFS) ≥ 1 vs patients with CFS=0. 
Bottom rows: patients with brainstem functional system (BFS) ≥ 1 vs patients with BFS=0. 
Overlap between T2 lesion probability maps and abnormalities of DT MRI indices are also shown 
in green. Images are in neurological convention. From Preziosa et al. 2014 with permission. 
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 Figure 3: Macroscopic cerebellar pathology in MS 
 
T1-weighted images (3D MPRAGE) of a 31 y/o woman with RRMS (upper row) presenting only 
with mild cerebellar disability (cerebellar FSS 1) after 9 years disease duration and a sex- and age-
matched healthy control are displayed in coronal, axial and sagittal view (left to right). Lesional 
pathology (dashed circle) and macroscopic detectable global volume loss can easily be seen. 
Cerebellar volume reduction is present with focus of the superior posterior lobe (VI and Crus I; 
arrows).
AC
CE
PT
ED
 M
AN
US
CR
IPT
 Table 1: Studies analysing associations between cerebellar functions and MRI metrics in patients with multiple sclerosis (chronological 
order). 
 
Author/year 
Type of 
study 
No. of subjects 
per study group 
MRI outcome measures  Clinical assessment 
Clinico-radiological correlations 
(main findings)  
Additional findings 
Davie et al. 
1995 
Cross-
sectional 
Controls = 11 
Cerebellar GM and WM 
volume 
EDSS 
Moderate negative rank 
correlation of NA-level and EDSS 
and cFSS in all RRMS 
Reduced NA-levels in the 
cerebellar ROI of impaired RRMS 
vs non-impaired RRMS  
RRMS 
"cerebellar 
impaired" = 11 
NA spectroscopy in 
cerebellar ROI 
Kurtzke functional 
cerebellar scale  
RRMS with severe cerebellar 
dysfunction ("impaired") 
demonstrated significant reduction 
of median cerebellar volume and 
greater posterior fossa LV 
RRMS 
"cerebellar non-
impaired" =11 
   Positive correlation between NA-
level and cerebellar volume 
(ADCA = 8)       
Hickman et al. 
2001 
Cross-
sectional 
RRMS = 2 Whole brain T2- and T1-LV EDSS 
Moderate positive correlation 
between EDSS and no. of 
infratentorial T1 hypointense 
lesions per patient  
No correlation between EDSS and 
whole brain T1- or T2-LV, or 
infratentorial T2-LV 
SPMS = 7 
Infratentorial T2- and T1-
LV 
Cerebellar FSS 
Strong positive correlation 
between EDSS and infratentorial 
T1 LV per patient 
  
  
No. of infratentorial T1-
hypointense lesions 
      
Saini et al. 
2004 
Cross-
sectional 
Controls = 11 
Functional connectivity 
analysis of primary motor 
cortex; premotor cortex, 
Crus I and dentate nucleus 
EDSS 
No correlation between 
lateralisation index or regional 
signal change and EDSS, brain 
volumes or LV 
No "crossed" connectivity between 
left primary motor cortex and right 
cerebellar dentate nucleus in 
patients, but in HC 
RRMS = 14 Whole brain T2-LV Simple fMRI motor task  
 
Ipsilateral connectivity between left 
premotor neocortex and left 
cerebellar cortex (Crus I) in 
patients, but not in HC 
  Normalized brain volume       
            (Table continues on next page) 
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 Author/year 
Type of 
study 
No. of subjects 
per study group 
MRI outcome measures  Clinical assessment 
Clinico-radiological correlations 
(main findings)  
Additional findings 
 Continued from previous page 
   
  
Tjoa et al. 
2005 
Cross-
sectional 
Controls = 15 Whole brain T2- and T1-LV EDSS 
Weak negative correlation 
between dentate T2-hypointensity 
and 25-FWT 
T2-hypointensity present 
throughout subcortical GM in MS 
vs controls 
RRMS = 47 Whole brain volume (BPF) 25-FWT Dentate T2-hypointensity was best 
MRI correlate of physical 
disability (EDSS) 
  
SPMS = 6 Subcortical grey matter T2-
hypointensity measurements 
(incl. dentate nucleus) 
 
  
        
Measaros et al. 
2008 
Cross-
sectional 
Controls = 21   Neuropsychological tests 
for: attention and 
information processing 
speed, verbal and visual-
spatial memory, executive 
functions, and spatial 
cognition 
  Significant cerebellar GM loss in 
SPMS vs BMS was the only 
distinctive measure; subgroup 
analysis: results consistent only in 
a subgroup of non cognitive 
impaired BMS patients and BMS 
patients with disease duration 
>20yrs and EDSS <2.0 
BMS = 60 
Voxel-based regional GM 
differences 
No correlation between EDSS and 
regional GM atrophy in any group 
SPMS = 35   EDSS   
No significant WM reduction 
between groups 
Anderson et al. 
2009 
Cross-
sectional 
Controls = 25   EDSS 
Cerebellar GM volume: reduced in 
patients with cerebellar 
dysfunction (cFSS>0); only 
significant predictor of cerebellar 
dysfunction; correlation between 
9-HPT and cerebellar GM volume 
Cerebellar GM volume: significant 
reduced in SPMS vs HC; 
borderline reduced in RRMS vs 
HC and CIS CIS = 29 
Cerebellar GM and WM 
volume 
Cerebellar FSS 
RRMS = 33 
 
9-HPT 
Cerebellar WM volume: 
borderline reduction in patients 
with cerebellar dysfunction 
(cFSS>0) 
Cerebellar WM volume: reduced 
only in SPMS vs HC 
SPMS = 11   25-FWT   
            (Table continues on next page) 
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 Author/year 
Type of 
study 
No. of subjects 
per study group 
MRI outcome measures  Clinical assessment 
Clinico-radiological correlations 
(main findings)  
Additional findings 
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Calabrese et al. 
2009 
Cross-
sectional 
Controls = 32 
Cerebellar GM and WM 
volume 
EDSS   Evidence of cerebellar GM atrophy 
and cortical LV in all MS group 
CIS = 38 Cerebellar leukocortical LV Cerebellar FSS Correlation of cerebellar GM 
volume and cerebellar cortical LV 
with clinical disability (cFSS, 
EDSS) 
RRMS = 35 
Brainstem and cerebellar 
T2-LV  
Weak correlation between 
cerebellar GM volume and T2-LV 
SPMS = 27 
Whole brain cortical GM 
volume   
Absence of cerebellar WM atrophy 
in CIS and RRMS patients 
PPMS = 25         
Valentino et al. 
2009 
Cross-
sectional 
RRMS 
"cerebellar non-
impaired" = 21 
 Regional T2-LV 
Neuropsychological testing 
for: verbal memory, spatial 
memory, visuo-spatial 
skills, sustained attention 
and processing speed, 
abstract/conceptual 
reasoning verbal fluency 
  
No significant between-goup-
difference of LV in any brain 
region  
 
significant between-group 
difference on tasks assessing 
processing speed/attention and 
language 
  
RRMS 
"cerebellar 
impaired" = 21 
 
no correlation between regional 
LV and tasks assessing processing 
speed/attention and language 
 
Rocca et al. 
2010 
Cross-
sectional 
Controls = 17 
Cognitive task based fMRI 
activity  
EDSS 
Increased activity of cerebellum, 
secondary sensorimotor cortex, 
and insula in cognitive impaired 
compared to non-impaired patients 
and HC 
No difference in structural MRI 
metrics between cognitive impaired 
and non-impaired patients PPMS = 16 Whole brain T2 LV 
Maximum finger tapping 
frequency 
 
Normalized brain volume 
Neuropsychological testing 
for: memory, attention and 
frontal lobe cognitive 
domains 
Correlation of decreased 
composite cognitive score with 
increased activity of cerebellum, 
insula and secondary sensorimotor 
cortex in cognitive impaired 
PPMS 
  
  Corpus callosal area   
            (Table continues on next page) 
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Rocca et al. 
2010 
Cross-
sectional 
Pediatric 
controls = 10 
Simple motor task based 
fMRI activity  
EDSS 
Increased intra- and 
interhemispheric strengths of 
coefficients of effective 
connectivity in adult CIS and 
RRMS 
Coefficients of effective 
connectivity of the sensorimotor 
network were similar in pediatric 
RRMS and HC Pediatric RRMS 
= 17 
Connectivity analysis 
between brain regions 
involved in motor task 
9-HPT 
Adult CIS = 16 
Whole brain and regional 
T2-LV 
Maximum finger tapping 
frequency 
Correlation of coefficients of 
effective connectivity with callosal 
and corticospinal tract damage, 
T2-LV and DTI metrics 
  
Adult RRMS = 
14 
DTI measures (FA, MD) of 
corpus callosum and 
corticospinal tract 
    
Anderson et al. 
2011  
Cross-
sectional 
Controls = 16 
Cerebellar GM and WM 
volume 
EDSS 
Cerebellar WM volume was 
associated with worse 
performance on upper limb tasks 
in PPMS 
FA in MCP of PPMS reduced 
when compared to HC and RRMS 
RRMS = 14 
DTI measures (FA, MD, 
AD and RD) from the SCP 
and MCP 
Cerebellar FSS 
No difference in any MRI measure 
between RRMS and HC 
PPMS = 12 
 
9-HPT 
Significant associations between 
SCP FA and upper limb function 
and SCP FA, MD and RD and 
walking ability in PPMS 
Extent of cerebellar WM damage 
was independent from GM damage 
in both groups of patients     25-FWT 
Prosperini et 
al. 2011 
Cross-
sectional 
RRMS = 21 Whole brain T2- and T1-LV  EDSS 
"Fallers" had higher EDSS, poorer 
static balance and greater T2-LV 
at brainstem and MCP level than 
"non-fallers" 
No difference between "fallers" vs 
"non-fallers" with respect to whole 
brain T1- and T2-LV, 
supratentorial LV and LV of paleo- 
and neocerebellum 
SPMS = 10 
ROI analysis of supra- and 
infratentorial LV 
Static posturography 
Positive correlation between 
brainstem T2-LV and impaired 
static standing balance in open eye 
condition 
  
    
Self-report of falling within 
past 6 months  ("fallers" vs 
"non-fallers")  
Association of greater MCP and 
brainstem T2-LV and wider 
displacement of body center of 
pressure in closed eye condition 
with recurrent falls 
  
            (Table continues on next page) 
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Sastre-Garriga 
et al. 2011 
Longitudinal 
(10 weeks 
period) 
Controls = 5 
Cognitive task based fMRI 
activity at baseline, pre and 
post rehabilitation 
Cognitive fMRI task: 
PASAT 
Detection of increased fMRI 
activity after rehabilitation in two 
regions of the right cerebellar 
hemisphere of cognitive impaired 
RRMS 
  
RRMS = 15 
Whole brain T2- and T1-
LV 
Neuropsychological tests: 
TMT, SDMT and Digit 
Span 
No correlation between cognitive 
improvement and regional activity 
increases 
  
  
EDSS   
Cerasa et al. 
2012 
Cross-
sectional 
Controls = 16 
Functional connectivity 
between cerebellar ROI and 
other brain regions Neuropsychological testing 
for: visuo-spatial skills, 
executive function, 
information processing 
speed and attention, verbal 
learning, working memory, 
and verbal fluency 
Greater cerebellar LV in 
"impaired" vs "non-impaired" 
patients 
  
RRMS 
"cerebellar 
impaired" = 12 
Supratentorial and 
cerebellar T2-LV 
Lower performance of "impaired" 
vs " non-impaired" patients in 
attention/working memory 
performance, abstract reasoning 
and verbal fluency task 
No correlation between 
supratentorial or cerebellar LV and 
cognitive outcome measures in 
either group 
RRMS 
"cerebellar non-
impaired" = 15 
Supratentorial and total 
cerebellar volume 
Activation of cerebellar Crus 
I/Lobule VI in "impaired" patients 
during PVSAT task 
  
  Intracranial volume 
Cognitive fMRI task: 
PVSAT 
Detection of altered connectivity 
between Crus I and superior 
parietal lobule in "impaired" 
patients 
  
Weier et al. 
2012 
Cross-
sectional 
Controls = 15 
Cerebellar GM and WM 
volume 
EDSS No correlation between EDSS 
/cerebellar FSS and normalized 
TCV 
Volume reduction of NBV and 
normalized TCV in MS vs HC 
RRMS = 15 Whole brain volume Cerebellar FSS 
MS = 15 
Cerebral and cerebellar 
lesion load 
      
Cerasa et al. 
2013 
Longitudinal 
(6 week 
period)  
"Experimental 
group" MS = 12 
Cognitive task based fMRI 
activity 
Cognitive fMRI task: 
PVSAT 
Association of increased abilities 
in attention task with increased 
activity in posterior cerebellar 
lobe 
  
"Control group" 
MS = 11 
Whole brain T2-LV FSS   
    MMSE     
            (Table continues on next page) 
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Prosperini et 
al. 2013 
Cross-
sectional 
Controls = 25 
Whole brain, supra- and 
infratentorial T2- and T1-
LV 
EDSS 
Correlation of severity of balance 
impairment in MS with worse DTI 
parameters along cerebellar 
connections and supratentorial 
associative WM bundles and with 
GM atrophy of anterior lobules 
and lobule VIII of the cerebellum 
MS patients had worse postural 
stability, widespread alterations in 
most WM bundles, and GM 
atrophy in several brain regions RRMS = 48 
Whole brain GM and WM 
volume 
Static posturography 
 
DTI measures (FA, MD, 
AD, RD)  
  
 
Voxel-based regional GM 
differences  
  
Damasceno et 
al. 2014 
Cross-
sectional 
Controls = 30 
Cerebellar WM and cortical 
(intra- and leukocortical) 
LV 
EDSS / cerebellar FSS 
High burden of cerebellar 
intracortical LV is only predictor 
for EDSS, cerebellar FSS and arm 
/ leg function 
High cerebellar leukocortical LV is 
only predictor of cerebellar WM 
volume 
RRMS = 42 
Whole brain WM and 
cortical LV 
9-HPT 
Patients with high cerebellar 
intracortical LV showed higher 
EDSS and cerebellar FSS, worse 
performance in 9-HPT, 25-FWT 
and SDMT 
  
 
Cerebellar WM and cortical 
volume 
25-FWT   
  
Whole brain WM and 
cortical volume 
SDMT, PASAT 
Correlation of high cerebellar 
leukocortical LV with lower 
PASAT scores 
  
Dogonowski et 
al. 2014 
Cross-
sectional 
Controls = 30 
Resting-state regional 
functional connectivity 
analysis (= homogeneity of 
BOLD-signal fluctuations) 
EDSS 
Regional homogeneity decrease in 
upper left cerebellar hemisphere 
(lobules V and VI) of MS vs 
controls 
Patients with higher LV showed 
stronger reduction in cerebellar 
homogeneity 
RRMS = 27 Whole brain T2-LV 
Ataxia score of Multiple 
Sclerosis Impairment Scale 
Correlation of higher EDSS / 
ataxia scores and reduced 
homogeneity in left posterior 
cerebellum (Crus I, Crus II and 
dentate nucleus) 
  
SPMS = 15 
T2-LV in cerebellar 
peduncles 
    
            (Table continues on next page) 
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Prosperini et al. 
2014 
Longitudinal 
(12 weeks 
period) 
Controls = 15 Whole brain T2-LV EDSS Relevant differences between patients 
and HC in postural sway and DTI 
parameters 
  
RRMS = 27 
Whole brain GM and WM 
volume 
Static posturography   
SPMS = 3 
Change of DTI measures (FA, 
MD, AD, RD)  
Correlation of changes in DTI metrics 
(FA and RD of SCP bilateral) with 
balance improvement, however not 
persistent beyond 12 weeks training 
period 
  
  
Voxel-based regional GM 
changes 
    
Weier et al. 2014 
Cross-
sectional 
MS "cerebellar 
non- impaired" = 
52 
Cerebellar GM and WM 
volume 
EDSS / cerebellar FSS 
Patients with cerebellar dysfunction 
("impaired") had lower TCV, NBV, 
and higher whole brain LV and 
showed worse performance in SDMT 
and PASAT 
None of the cerebellar metrics 
contribute to variance in FSMC 
Whole brain volume 9-HPT   
MS "cerebellar 
impaired" = 120 
Whole brain and cerebellar LV 
Neuropsychological testing 
(SDMT, PASAT) 
Cerebellar metrics explain partial 
variance of SDMT and PASAT 
performance 
  
  fatigue testing (FSMC)     
Weier et al. 2015 
Cross-
sectional 
Controls = 35 
Cerebellar GM and WM 
volume 
EDSS / cerebellar FSS 
Association of higher cerebellar LV 
with worse EDSS and 9-HPT 
performance in MS patients 
Focal atrophy pattern in NMO (upper 
cervical cord) 
RRMS = 25 Whole brain volume 9-HPT 
NMO = 30 Whole brain and cerebellar LV 25-FWT 
 
Diffuse atrophy pattern in MS (incl. 
cerebellum and whole brain, but not 
UCV) 
  Upper cervical cord volume   
 
Deppe et al. 
2016 
Cross-
sectional 
Controls = 26 
Cerebellar GM and WM 
volume 
EDSS FA reduction in absence of lesions   
"early" RRMS = 
23 
Whole brain GM and WM 
volume  Correlation of cerebellar FA reduction 
with EDSS, DD, and reduction in 
WMV-GMV ratio 
  
"late" RRMS = 45 Whole brain LV 
 
  
 
DTI measures (FA, MD, AD, 
RD) 
    
            (Table continues on next page) 
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Favaretto et al. 
2016 
Cross-
sectional 
CIS = 10 
cerebellar cortical and WM 
lesions 
EDSS / cerebellar FSS Correlation of cortical lesions with 
EDSS and DD 
PSIR improves cortcal lesion detection 
RRMS = 24 
  
  
SPMS = 6         
Weier et al. 2016 
Cross-
sectional 
pediatric cohort 
Cerebellar regional GM and 
WM volume 
EDSS Cerebellar posterior lobe volume and 
infratentorial LV accounted for extra 
variance on measures of information 
processing and vocabulary 
Reduced cognitive and motor 
performance in patients 
Controls = 33 Whole brain volume Comprehensive 
Neuropsychological testing  
  
RRMS = 28 Whole brain and cerebellar LV   
Weier et al. 2016 
Longitudinal 
(3.1 yrs) 
pediatric cohort Cerebellar GM and WM 
volume growth trajectories 
EDSS / cerebellar FSS 
No correlation with physical disability 
All patient groups failed to reach age-
expected cerebellar growth trajectories monoADS = 56 
 
ADEM = 20 Whole brain and cerebellar LV 
  
Reduced cerebellar volumes most 
notably in the posterior lobes 
MS = 22 
   
Cerebellar and cerebral volume 
reduction similar magnitude 
controls = 418 
   
No decline of cerebellar WM volume in 
monoADS patients 
D’Ambrosio et 
al. 2016 
cross-
sectional 
Controls = 32 
Cerebellar regional GM and 
WM volume 
EDSS 
T2 LV and anterior cerebellar volume 
as independent predictors of EDSS  
  
RRMS = 52 Whole brain volume 9-HPT 
Anterior cerebellar volume as 
independent predictor of 9-HPT  
  
benign MS = 20 Whole brain and cerebellar LV PASAT T2 LV and posterior cerebellar volume 
as independent predictors of SDMT 
score and PASAT 
  
SPMS = 23   SDMT   
Moroso et al. 
2017 
Cross-
sectional 
CIS = 37 
Cerebellar regional GM and 
WM volume 
EDSS / cerebellar FSS 
Reduction of cerebellar posterior 
lobules volume (esp. vermis) was 
associated with reduced measures of 
information processing  
Significant volume reduction of 
bilateral lobule VI, left crus I, right 
VIIb and TCV in patients vs HC RRMS = 32 Whole brain volume Comprehensive 
Neuropsychological testing  HC = 36 Whole brain and cerebellar LV   
Tobyne et al. 
2017 
Cross-
sectional 
MS "cognitive 
non- impaired" = 
16 
Cerebellar lesion location 
EDSS 
No correlation of cerebellar lesion load 
with EDSS 
predilection of middle cerebellar 
peduncle lesion occurence in cognitive 
impaired MS 
Cerebellar GM and WM 
volume 
MS "cognitive 
preserved" = 15 
Whole brain GM and WM 
volume Comprehensive 
Neuropsychological testing  
Correlation of hemispheric lesion load 
with EDSS 
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 Abbreviations (alphabetical order):  
ADCA = autosomal dominant cerebellar ataxia; AD = axial diffusivity; ADEM = acute disseminated encephalomyelitis; BMS = benign MS; BPF =  
brain parynchemal fraction; BRB-N = Brief Repeatable Battery of Neuropsychological Tests; BVC = brain volume change; CIS = clinically isolated 
syndrome; cFSS =  cerebellar Functional System Scale; DTI = diffusion tensor imaging; EDSS = Expanded Disability Status Scale; FA = fractional 
anisotropy;  fMRI = functional magnetic resonance imaging; FSS = Fatigue Severity Scale; 25-FWT =  timed 25 foot walk test; GM = grey matter; 9-
HPT = 9 hole peg test; HC = healthy controls; LV = lesion volumes; MCP = middle cerebellar peduncle; MD = mean diffusivity; MMSE = Mini Mental 
Status Exam; monoADS = monophasic acute demyelinating syndrome; MS = multiple sclerosis; NA = N-acetyl group; NBV = normalized brain volume; 
PASAT = Paced Auditory Serial Addition Test; PVSAT = Paced Visual Serial Addition Test; PPMS = primary progressive MS; RD = radial diffusivity; 
RRMS = relapsing-remitting MS; ROI = region of interest; SCP = superior cerebellar peduncle; SDMT = Symbol Digit Modality Test; SPMS = 
secondary progressive MS; TCV = total cerebellar volume; TMT = Trail Making Test; UCV = upper cervical cord volume; vs = versus; WM = white 
matter; WCST = Wisconsin Card sorting Test. 
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